146 related articles for article (PubMed ID: 19683335)
1. Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells.
Wu B; Liu Q; Duan C; Li Y; Yu S; Chan P; Uéda K; Yang H
Acta Histochem; 2011 Jan; 113(1):32-5. PubMed ID: 19683335
[TBL] [Abstract][Full Text] [Related]
2. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells.
Kim SS; Moon KR; Choi HJ
Arch Pharm Res; 2011 May; 34(5):837-45. PubMed ID: 21656370
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein.
Zhou ZD; Yap BP; Gung AY; Leong SM; Ang ST; Lim TM
Exp Cell Res; 2006 Jan; 312(2):156-70. PubMed ID: 16297908
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
Tehranian R; Montoya SE; Van Laar AD; Hastings TG; Perez RG
J Neurochem; 2006 Nov; 99(4):1188-96. PubMed ID: 16981894
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
8. A role for alpha-synuclein in the regulation of dopamine biosynthesis.
Perez RG; Waymire JC; Lin E; Liu JJ; Guo F; Zigmond MJ
J Neurosci; 2002 Apr; 22(8):3090-9. PubMed ID: 11943812
[TBL] [Abstract][Full Text] [Related]
9. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
J Neurochem; 2006 Feb; 96(4):950-9. PubMed ID: 16412098
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
[TBL] [Abstract][Full Text] [Related]
12. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
Klongpanichapak S; Phansuwan-Pujito P; Ebadi M; Govitrapong P
Neurosci Lett; 2008 May; 436(3):309-13. PubMed ID: 18406059
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.
Li YH; Gao N; Ye YW; Li X; Yu S; Yang H; Uéda K; Chan P
Acta Neurol Belg; 2011 Jun; 111(2):130-5. PubMed ID: 21748932
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.
Alberio T; Bossi AM; Milli A; Parma E; Gariboldi MB; Tosi G; Lopiano L; Fasano M
FEBS J; 2010 Dec; 277(23):4909-19. PubMed ID: 20977677
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.
Yu S; Zuo X; Li Y; Zhang C; Zhou M; Zhang YA; Uéda K; Chan P
Neurosci Lett; 2004 Aug; 367(1):34-9. PubMed ID: 15308292
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
[TBL] [Abstract][Full Text] [Related]
18. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
[TBL] [Abstract][Full Text] [Related]
19. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.
Peng X; Tehranian R; Dietrich P; Stefanis L; Perez RG
J Cell Sci; 2005 Aug; 118(Pt 15):3523-30. PubMed ID: 16030137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
